Industry News
Biotechnology Industry News
With IL-12 prospect nearing clinic, Ankyra inks NCI pact to support cancer pipeline progress
With IL-12 prospect nearing clinic, Ankyra inks NCI pact to support cancer pipeline progress ntaylor Mon, 04/18/2022 - 08:47
Emergex’s synthetic T-cell adaptive vaccines close in on data in dengue, COVID-19
Emergex's synthetic T-cell adaptive vaccines close in on data in dengue, COVID-19 ntaylor Mon, 04/18/2022 - 08:13
U2 disbands: In a crushing step back, TG retracts FDA request for combo therapy due to death risk
U2 disbands: In a crushing step back, TG retracts FDA request for combo therapy due to death risk mbayer Fri, 04/15/2022 - 10:38
UPDATE: TG disbands cancer program after pulling FDA request for U2 combo therapy
UPDATE: TG disbands cancer program after pulling FDA request for U2 combo therapy mbayer Fri, 04/15/2022 - 10:38
Dutch courage: Netherlands makes $350M bet on patient-centered preclinical cancer drug development
Dutch courage: Netherlands makes $350M bet on patient-centered preclinical cancer drug development ntaylor Fri, 04/15/2022 - 03:27
Game over: Bristol Myers, Nektar end $3.6B immuno-oncology program after 2 more late-stage flops
Game over: Bristol Myers, Nektar end $3.6B immuno-oncology program after 2 more late-stage flops ntaylor Fri, 04/15/2022 - 02:35
Chutes & Ladders—Former CVS exec Denton, responsible for Aetna merger, tapped by Pfizer for CFO role
Chutes & Ladders—Former CVS exec Denton, responsible for Aetna merger, tapped by Pfizer for CFO role mbayer Thu, 04/14/2022 - 23:05
AstraZeneca’s Alexion, Arvinas nab space at future 10-story biotech tower in New Haven
AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven gmasson Thu, 04/14/2022 - 17:29
FDA urges creation of racial, ethnic recruitment plans for clinical trials
FDA urges creation of racial, ethnic recruitment plans for clinical trials gmasson Thu, 04/14/2022 - 13:58
Evelo hits the brakes on atopic dermatitis drug development after phase 1 failure
Evelo hits the brakes on atopic dermatitis drug development after phase 1 failure jwaldron Thu, 04/14/2022 - 11:52
UPDATE: Magenta cuts 14% of staff, trims R&D amid tumultuous biotech markets
UPDATE: Magenta cuts 14% of staff, trims R&D amid tumultuous biotech markets mbayer Thu, 04/14/2022 - 10:10
Be Bio uses Arch Venture-led $130M financing round to harness ‘power of the B cell’
Be Bio uses Arch Venture-led $130M financing round to harness 'power of the B cell' gmasson Thu, 04/14/2022 - 09:39
Editas brings on Sarepta CMO—for CEO swap, not the vacant CMO role
Editas brings on Sarepta CMO—for CEO swap, not the vacant CMO role aarmstrong Thu, 04/14/2022 - 08:55
Merck’s next-gen pneumococcal vaccine receives FDA breakthrough status ahead of phase 3 trial
Merck's next-gen pneumococcal vaccine receives FDA breakthrough status ahead of phase 3 trial jwaldron Thu, 04/14/2022 - 08:50
Twist in Protagonist story as FDA seeks to rescind breakthrough nod ‘based on observed malignancies’
Twist in Protagonist story as FDA seeks to rescind breakthrough nod 'based on observed malignancies' ntaylor Thu, 04/14/2022 - 06:17
Chasing Roche, AbbVie posts data on CD20 blood cancer bispecific ahead of race to regulators
Chasing Roche, AbbVie posts data on CD20 blood cancer bispecific ahead of race to regulators ntaylor Thu, 04/14/2022 - 04:56
CDx Biomarkers for Oncology Research & Development
CDx Biomarkers for Oncology Research & Development mwen Wed, 04/13/2022 - 11:33
ProQR slashes 30% of workforce following phase 2/3 blunder
ProQR slashes 30% of workforce following phase 2/3 blunder mbayer Wed, 04/13/2022 - 10:51
Cardiff Oncology’s chief medical officer exits after less than a year
Cardiff Oncology's chief medical officer exits after less than a year gmasson Wed, 04/13/2022 - 10:40
Swiss biotech CDR Life uses $76M series A funding round to ready T-cell engagers for clinic
Swiss biotech CDR Life uses $76M series A funding round to ready T-cell engagers for clinic mbayer Wed, 04/13/2022 - 08:37